healthcare stocks

After a stunning share price run, 4D Medical has plenty of believers and sceptics. CEO Dr Andreas Fouras makes the case for what comes next.

Consensus forecasts for ASX healthcare stocks suggest the market is punishing something other than a genuine earnings collapse.

The reset has created winners and losers. From small caps to global leaders, four experts share where they see value emerging in healthcare.

A near 40% drawdown has forced investors to reassess the healthcare sector. Is this a reset, or are deeper cracks starting to emerge?

One Australian healthcare company has quietly bucked the trend in 2025 and is up over 500% in a year.

Healthcare has been on life support throughout 2025, but there's signs of revival. Here are two ASX stocks that are looking healthy.

ASX healthcare’s been flatlining, could a recovery be on the cards? Two top investors name the stocks they think could revive the sector.

With a 20-year CAGR of 14.1%, Thermo Fisher has repeatedly shown how temporary headwinds create long-term value for patient shareholders.

With the ability to offset the impact of tariffs and strong historical performance in tough times, the health sector could be one to watch.

What the market is missing on this healthcare stock